History

How the Story Changed

For three years, TAZMO told a coherent and credible story: a small Okayama specialist in coaters and clean-transfer robots, riding a multi-year SiC power-semiconductor capex cycle, with cash flow steadily catching up to a balance sheet stretched by inventory build. That story peaked in FY2024 — a record year that beat the 3-year Vision 2024 plan on profit by wide margins. In FY2025 the story silently changed: power semis got demoted to "medium to long term," AI-driven advanced packaging became the single growth engine, and management's old margin promise broke. The reader should read FY2026 as a stretched, single-theme bet, not as continuity.

1. The Narrative Arc

Anchors for every other tab to use:

• Current CEO: Yasuyuki Sato (Representative Director and President, born 1965) has signed every kessan tanshin in the FY2021–FY2026 record. The pre-2021 record needed to date his tenure start precisely is outside the loaded data; treat him as continuous leadership through the period under review.
• Current strategic chapter began in 2022. Three things changed in one year: listing was transferred to the TSE Prime Market in April 2022; the company raised ¥3,495M via a public offering, lifting paid-in capital to ¥3.57B; the SHAOXING (Zhejiang) China subsidiary was established; and the "TAZMO Vision 2024" three-year plan was published with FY2024 targets of ¥33.9B sales and 13.7% ordinary-income margin. Everything since is execution against that frame.
• Current leadership inherited a high-quality engineering franchise, not a turnaround. The photoresist coater (1989), the TFT colour-filter system (1994), the 3M license (2013), and the Apprecia / Quark / Facility consolidations (2017–2019) all predate the Vision 2024 chapter. What this leadership has done is choose which of those legacy product lines to ride and which to quietly fold away.

2. What Management Emphasized — and Then Stopped Emphasizing

The presentation decks are surprisingly explicit about which themes are rising and which are being demoted. The pattern reads like a relay: Coater/FPD hands off to Power-semi/SiC in 2022–2023, which hands off to Advanced Packaging/AI in 2024–2025, which is now handing off — speculatively — to LAB and DTB for 2026 and beyond.

What changed materially across the period — not in tone but in fact:

• Coater is being administratively disappeared. From FY2026, the "Coater" line item is folded into "Semiconductor equipment" in segment reporting. This follows a –65.5% FY2025 collapse to ¥849M from ¥2.5B. The line that the founding management built the company on (CS13 from 2001; the TFT colour-filter system from 1994) is being absorbed.
• Power semi / SiC went from "near-term driver" to "medium-to-long term." FY2023 commentary credited SiC explicitly with driving sales and profits. By FY2025 the same theme is described as "Strong capital investment appetite over the medium to long term, driven by EV market expansion, renewable energy, and data centers" — with the operative phrase being "near-term focus on Chinese market." The carry-out for power semi slipped a full cycle.
• Advanced packaging / AI was not a 2022 plan theme. Vision 2024 (Feb 2022) projected FY2024 semiconductor equipment sales of ¥9.9B. FY2024 actual semiconductor equipment came in at ¥12.3B; FY2025 at ¥17.2B. Almost all the upside came from a single category — advanced-packaging tools — that did not exist in the 2022 plan in any meaningful way.
• LAB and DTB are new product hopes. First commercial LAB sale was early 2026; DTB ships a demo unit in FY2026 and is targeted for mass production in 2027. Shipment forecasts in the FY2025 deck go from 0 units in 2025 to 16 LAB and ~24 DTB by 2031. These are not revenue today; they are story.
• Buybacks appeared in FY2025. Treasury-share purchases were ¥512M in FY2025 versus essentially zero historically. The dividend has stepped up every year since FY2020 (¥16 → ¥21 → ¥24 → ¥33 → ¥34); the FY2026 dividend is held flat at ¥34 against a –29% earnings forecast, lifting payout to 19.9%.

3. Risk Evolution

The kessan tanshin doesn't carry a formal "Risk Factors" section the way a US 10-K does, but the forward-looking commentary, the order-backlog charts, and the "Business Environment" pages disclose which risks management is currently confronting. The change across the period is sharp.

Read this risk grid right-to-left. The risks that were dominant when the chapter opened — pandemic supply chain, working capital pressure from the inventory build, FPD/coater secular decline — are either resolved or in run-off. The risks dominant today did not exist in the FY2021 risk frame: mix-shift margin compression (a brand-new risk that arrived in FY2025 with the advanced-packaging shift), AI concentration risk, the ¥7B capex execution risk for Ibara City and TAZMO Vietnam (Tay Ninh), and the LAB/DTB go-to-market execution. The shape of TAZMO's risk has rotated from cyclical-industrial to growth-bet, and the rotation happened in a single year (FY2024→FY2025).

What's missing from management's risk frame — and worth flagging — is customer concentration in advanced packaging. FY2025 semiconductor equipment ¥17.2B is now 49% of group revenue and is the only growing line. The kessan tanshin doesn't quantify who the customers are. The March 2026 yukashoken hokokusho (annual securities report) is scheduled to be the first time formal Risk Factors are published; that filing is the one to read carefully.

4. How They Handled Bad News

A consistent pattern emerges across the five years. When sales miss the initial plan, management leads with profit — which it has historically beaten — and attributes the sales gap to "delays in inspection and acceptance" rather than to demand weakness. When profit also misses (FY2025), the language shifts to "mix shift."

5. Guidance Track Record

Three years of Vision 2024 plus three years of full-year guidance give a usable record. The headline pattern: profit beats, sales miss — until FY2025, when both broke.

The Vision 2024 plan itself was reasonable in aggregate: FY2024 sales target ¥33.9B vs actual ¥35.9B (+5.9%); ordinary-income margin target 13.7% vs actual 16.7%. Plan kept on margin, beaten on revenue. The annual guides issued after Vision 2024 ended have been progressively less reliable — particularly the FY2025 initial guide of ¥41B / ¥5B / ¥3.5B net income, which had to be cut ¥5B mid-year and still missed.

Credibility score: 6/10. Above-average for a Japanese smid-cap semiconductor-equipment maker. Vision 2024 was published with specific numbers, executed roughly as promised, and on the profit line over-delivered. The discipline broke in FY2025: an initial guide that proved 14% too aggressive on sales, requiring a mid-year cut, with no public explanation of what changed between February and November. The Q1 FY2026 print arriving at OP −93% YoY while FY2026 guidance is "unchanged" puts credibility on the line for the rest of FY2026. If guidance is hit, credibility climbs back toward 7; if it's cut by mid-year, the rating belongs at 4–5.

6. What the Story Is Now

Today's TAZMO is a smaller, more focused, more concentrated bet than the Vision 2024 TAZMO.

De-risked since 2022:

• Balance sheet — equity ratio went from 43.9% (end-FY2022) to 56.6% (end-FY2025); long-term borrowings have been amortising; cash and deposits sit at ¥16.3B.
• Working capital — the inventory and WIP overhang that produced two consecutive years of negative operating cash flow (FY2022 −¥1.5B, FY2023 −¥0.3B) cleared in FY2024 (+¥7.5B) and FY2025 (+¥9.3B). Free cash flow has been positive for two years.
• The legacy headwinds — coater/FPD decline, the precision-molding loss-maker — have been resized and are no longer drags. Precision molding returned to profit in FY2025 after fixed-cost cuts.

Stretched today:

• Revenue concentration. Semiconductor equipment (advanced packaging) is 49% of group sales and is the only growing line. Cleaning −68.8%, coater −65.5%, transfer −7.9% in FY2025. The diversified equipment maker of 2021 is now an advanced-packaging specialist with three under-utilised side businesses.
• Margin trajectory. Operating margin peaked at 16.5% in FY2024 and is guided to 10.1% in FY2026 (with Q1 FY2026 actual at 1.4%). The mix shift to advanced packaging is dilutive.
• The capex bet. ¥7.0B FY2026 capex is roughly five times the FY2024–FY2025 run rate — covering Ibara City expansion, the new TAZMO Vietnam (Tay Ninh) facility, and demonstration equipment for LAB and DTB. This is a multi-year cash drag (FY2026 net cash change −¥5.9B per management's cash-allocation slide) before any of LAB/DTB's projected shipments arrive in volume.
• Order backlog. Down from ¥40B peak (end-FY2023) to ¥19.7B (end-FY2025) — a 51% reduction. Even if the advanced-packaging story is intact, near-term revenue cover has halved.

What to believe and what to discount:

Believe	Discount
The advanced-packaging tools work and are getting accepted (FY2024–FY2025 semi-equipment growth is in actuals, not orders).	The 5x capex step-up will produce the implied revenue lift within the FY2026 fiscal year.
The company has earned the right to swing for new categories — FY2024 record was real, not financial-engineering.	The "medium to long term" power-semi recovery will land in time to backfill the FY2026 hole.
Balance sheet can absorb a year of profit pressure without forced action.	The unchanged FY2026 guide is operational. The Q1 print says it isn't.

Bottom line. The current story is simpler than the FY2022 story (one engine: AI/advanced packaging; one big capex line: Ibara + Vietnam; one credibility test: the H2 FY2026 inflection). Simpler is not safer — it's more leveraged. Credibility on the operating record has been steady-to-improving, but the FY2025 guide miss and the Q1 FY2026 collapse have shortened the rope. The reader who used to underwrite TAZMO as a cyclical Japanese specialty-equipment compounder should now underwrite it as a single-theme advanced-packaging bet, with a year of capex and earnings pressure before the next inflection.